TWOEquity · Weekly research terminal

8432

TSH Biopharm Corporation Limited

TW Healthcare Drug Manufacturers - Specialty & Generic

Latest week
14 Aug 2026
Weekly close
50.50 TWD
Fair value
50.32 TWD
Next-week expectancy
Undecided 51.17%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

8432

TSH Biopharm Corporation Limited

Healthcare Drug Manufacturers - Specialty & Generic

TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan. The company offers prescription medication for cardiovascular, central nervous, gastrointestinal, and others. It also provides MPap, a methylation-specific qPCR technology to detect the methylation status of CDO1 and BHLHE22 genes using cervical scraping; AlphaLiquid Detect, a hybrid capture NGS-based liquid biopsy test designed for MRD detection and surveillance in stage I-III solid tumor patients; AlphaLiquid 100, a liquid biopsy test designed …

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
1,939,099,008
Fair value reference
50.32
Next-week expectancy
Undecided · 51.17%

Over the latest 12 completed weeks ending 2026-08-14, 8432 rose 4.75%, moving from 48.21 to 50.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -29.28 and has improved across the 12-week window. Market Dynamics is 0.31 on the latest week. Next-week expectancy is undecided at 51.17% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
50.50
12-Week Change
4.75%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 51.17%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
50.50
12-Week Change
4.75%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 51.17%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-29.28
Market Dynamics
0.31

Over the latest 12 completed weeks ending 2026-08-14, 8432 rose 4.75%, moving from 48.21 to 50.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -29.28 and has improved across the 12-week window. Market Dynamics is 0.31 on the latest week. Next-week expectancy is undecided at 51.17% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
6446 PharmaEssentia Corporation TAI 14 Aug 2026 1200.00 1550.00 1190.00 1500.00 25.00%
6932 Merdury Biopharmaceutical Corporation TWO 14 Aug 2026 5.13 8.63 5.01 6.02 17.35%
7829 Yoda Pharmaceuticals Inc. TWO 14 Aug 2026 39.85 46.35 39.85 44.90 12.67%
4747 Johnson Chemical Pharmaceutical Works Co., Ltd. TWO 14 Aug 2026 49.70 58.10 49.70 54.50 9.66%
6467 TAHO Pharma TWO 14 Aug 2026 114.00 130.00 114.00 125.00 9.65%
6621 UniPharma Co., Ltd. TWO 14 Aug 2026 11.00 11.95 10.60 11.65 5.91%
6539 DV Biomed Co., Ltd. TWO 14 Aug 2026 40.30 42.40 38.30 42.40 5.21%
4172 InnoPharmax Inc. TWO 14 Aug 2026 10.95 11.45 10.70 11.45 4.57%
1780 Allied Biotech Corporation TWO 14 Aug 2026 22.75 23.75 22.30 23.75 4.40%
6483 Original BioMedicals Co., Ltd. TWO 14 Aug 2026 13.50 14.10 13.50 14.05 4.07%
6785 Alar Pharmaceuticals Inc. TWO 14 Aug 2026 98.10 104.00 96.50 100.00 1.94%
4114 Synmosa Biopharma Corporation TWO 14 Aug 2026 29.30 30.15 29.05 29.80 1.71%
3705 YungShin Global Holding Corporation TAI 14 Aug 2026 53.50 54.50 53.00 54.30 1.50%
7860 TEH SENG TWO 14 Aug 2026 71.20 74.00 68.50 72.00 1.12%
4108 PhytoHealth Corporation TAI 14 Aug 2026 11.15 11.25 10.90 11.25 0.90%
6576 Foresee Pharmaceuticals Co., Ltd. TWO 14 Aug 2026 79.00 80.70 78.70 79.70 0.89%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context